Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats-Reference-Cited by-同舟云学术

Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats

Published:2023-02 Issue: Volume:372 Page:101-109
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Salin Raj P.,Nair Anupama,Preetha Rani M.R.,Rajankutty K.,Ranjith S.,Raghu K.G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Ferulic acid improves cardiovascular and kidney structure and function in hypertensive rats;Alam;J. Cardiovasc. Pharmacol.,2013

2. Anti-hypertensive effect of cereal antioxidant ferulic acid and its mechanism of action;Alam;Front. Nutr.,2019

3. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle;Arany;Cell Metab.,2005

4. A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease;Area-Gomez;Cell Death Dis.,2018

5. Mitochondrial fission and fusion in secondary brain damage after CNS insults;Balog;J. Cereb. Blood Flow Metab.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal denervation improves mitochondrial oxidative stress and cardiac hypertrophy through inactivating SP1/BACH1-PACS2 signaling;International Immunopharmacology;2024-11

2. Mitochondria-associated endoplasmic reticulum membranes as a therapeutic target for cardiovascular diseases;Frontiers in Pharmacology;2024-04-17

3. Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment;Cell Death Discovery;2024-03-20

4. So close, yet so far away: the relationship between MAM and cardiac disease;Frontiers in Cardiovascular Medicine;2024-02-05

5. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: An update since 2010;Pharmacological Research;2024-02